Cardene Iv Injection, Solution
Product Images NDC 43066-029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cardene Iv (NDC 43066-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cardene Structural Formula (Image 01)

Cardene Structural Formula (Image 01)
Chemical structure diagram of nicardipine hydrochloride, showing its molecular composition and arrangement including aromatic rings, nitrogen, oxygen atoms, and the hydrochloride salt (HCl). The molecular formula C26H29N3O6·HCl is displayed.*
FDA Label Image

Cardene 43066-029-01 Container Label (Image 02)

Cardene 43066-029-01 Container Label (Image 02)
Label for CARDENE I.V. nicardipine hydrochloride injection, 25 mg/10 mL (2.5 mg/mL) intravenous solution, single-dose vial containing 10 mL. Label includes storage instructions, dilution warning, manufacturer Baxter Healthcare Corporation, and barcode. Product is prescription only.*
FDA Label Image

Cardene 43066-029-10 Carton Label 1 Of 2 (Image 03)

Cardene 43066-029-10 Carton Label 1 Of 2 (Image 03)
The packaging label for CARDENE I.V. 25 mg/10 mL (2.5 mg/mL) injection, containing nicardipine hydrochloride, an intravenous solution. The box contains 10 single-dose vials, each 10 mL, manufactured by Baxter Healthcare Corporation. The label prominently warns that the product must be diluted before infusion and for intravenous infusion after dilution only.*
FDA Label Image

Cardene 43066-029-10 Carton Label 2 Of 2 (Image 04)

Cardene 43066-029-10 Carton Label 2 Of 2 (Image 04)
CARDENE IV 2.5 mg/10 mL injection solution label for intravenous use by Baxter Healthcare Corporation. The label details active ingredients per milliliter, storage instructions at controlled room temperature 20° to 25°C (68° to 77°F), and includes a caution to protect the light. The label also notes stability of the diluted solution for 24 hours at room temperature and trademark information for Cardene.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.